• SyntekaBio corrected its disclosure on a share-collateral contract that could change its largest shareholder.
• The collateral period end date was extended to Oct. 30, 2026 from Sept. 30, 2026.
• The pledge covers 2,800,000 shares tied to KRW 2.85 billion in borrowing, with collateral set at KRW 5.04 billion.
• Full enforcement would cut the pledgor’s stake to 758,849 shares from 3,558,849, reducing ownership to 3.13% from 14.67%.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SyntekaBio Inc. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20260930901014), on September 30, 2026, and is solely responsible for the information contained therein.